Clearside Biomedical (NSDQ:CLSD) today named Dr. Richard Beckman as chief medical officer. The ophthalmologist has 13 years of clinical practice under his belt, as well as 20 years of corporate executive and consultancy experience.
Prior to joining Clearside, Beckman managed a pharmaceutical and medical device industry consulting firm. He has previously served as CMO and general manager of the ocular and novel drug delivery systems business unit at Unilife Corporation. He has also worked with a slew of pharmaceutical companies, including Ophthotech Pharmaceuticals, Danube Pharmaceuticals, Becton-Dickinson, Alcon Laboratories, and Allergan.
Get the full story at our sister site, Drug Delivery Business News.
The post Clearside Biomedical names Beckman as new CMO | Personnel Moves, Jan. 5, 2017 appeared first on MassDevice.